Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2007-10-02
2007-10-02
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
C558S052000
Reexamination Certificate
active
10499042
ABSTRACT:
A compound of formula Iwherein R1represents chloro, fluoro or hydroxy as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, prodrugs, solvates and crystalline forms thereof, processes for preparing such compounds, their utility in treating clinical conditions associated with insulin resistance, methods for their therapeutic use and pharmaceutical compositions containing them.
REFERENCES:
patent: 5232945 (1993-08-01), Hulin
patent: 5306726 (1994-04-01), Hulin
patent: 6884821 (2005-04-01), Shinoda et al.
patent: 6906058 (2005-06-01), Starke et al.
patent: 7125864 (2006-10-01), Starke et al.
patent: 7132416 (2006-11-01), Starke et al.
patent: 2004/0102634 (2004-05-01), Matsuura et al.
patent: 1216980 (2002-06-01), None
patent: 1380562 (2004-01-01), None
patent: 9801990-4 (1998-06-01), None
patent: 91/19702 (1991-12-01), None
patent: 99/29640 (1999-06-01), None
patent: 99/62871 (1999-09-01), None
patent: 99/62872 (1999-09-01), None
patent: 99/62871 (1999-12-01), None
patent: 99/62872 (1999-12-01), None
patent: 00/64888 (2000-11-01), None
patent: 01/25181 (2001-04-01), None
patent: WO 01/25181 (2001-04-01), None
patent: 01/40170 (2001-06-01), None
patent: 01/40172 (2001-06-01), None
patent: 01/66098 (2001-09-01), None
patent: WO 01/66533 (2001-09-01), None
patent: WO 02/32428 (2002-04-01), None
patent: WO 02/50051 (2002-06-01), None
patent: 02/096863 (2002-12-01), None
patent: 02/100812 (2002-12-01), None
patent: WO 02/100812 (2002-12-01), None
patent: WO 03/020710 (2003-03-01), None
patent: WO 03/022286 (2003-03-01), None
patent: WO 03/022825 (2003-03-01), None
patent: WO 03/022830 (2003-03-01), None
patent: WO 03/051821 (2003-06-01), None
patent: WO 03/051822 (2003-06-01), None
patent: WO 03/091232 (2003-11-01), None
patent: WO 03/106482 (2003-12-01), None
patent: WO 2004/000294 (2003-12-01), None
patent: WO 2004/000295 (2003-12-01), None
patent: WO 2004/000790 (2003-12-01), None
patent: WO 2004/056748 (2004-06-01), None
patent: WO 2004/110984 (2004-12-01), None
patent: WO 2004/110985 (2004-12-01), None
patent: WO 2004/113276 (2004-12-01), None
patent: WO 2004/113282 (2004-12-01), None
patent: WO 2004/113283 (2004-12-01), None
patent: WO 2004/113284 (2004-12-01), None
patent: WO 2004/113285 (2004-12-01), None
Willson et al., J Med. Chem. Feb. 24, 2000, vol. 43, pp. 527-550.
Cronet et al., Structure, Aug. 2001, vol. 9, pp. 699-706.
Alstermark Lindstedt Eva-lotte
Boije Anna Maria Persdotter
Holm Patrick
AstraZeneca AB
Freistein Andrew B.
McKane Joseph K.
Morgan & Lewis & Bockius, LLP
LandOfFree
3-Phenyl-2-arylalkylthiopropionic acid derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Phenyl-2-arylalkylthiopropionic acid derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Phenyl-2-arylalkylthiopropionic acid derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3894382